Flux Power Holdings Inc vs Hinge Health Inc. Class A Common Stock — how do they compare? Flux Power Holdings Inc trades at $0.43 (market cap $10.06M), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 842.9× Flux Power Holdings Inc's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Flux Power Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Flux Power Holdings Inc for 21 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| FLUX | HNGE | |
|---|---|---|
Market Cap | $10.06M | $8.48B |
Volume | 188,430 | 879,799 |
Sector | Industrials | Health |
52-Week High | $6.66 | $105.14 |
52-Week Low | $0.41 | $31.17 |
Typical Hold Time | 21 Days | 0 Days |
Enterprise Value | $18.26M | $8.10B |
Signals from Pluang's Aura AI — not financial advice
FLUX trades at $0.4652, down 0.04% on the day, with a bearish technical signal from moving averages despite neutral oscillators. The company reported revenue of $66.43 million in 2025 but posted a net loss of $6.67 million, with profitability metrics showing negative ROE and ROA. Recent news highlights acquisition interest from Solidion Technology, which Flux Power's board rejected in October 2026, creating uncertainty around strategic direction.
The outlook remains challenged by persistent losses and declining revenue projections for 2026, though analyst consensus is unanimously bullish with 6 buy ratings. Key risks include execution on profitability, competitive pressures in energy storage, and potential acquisition volatility. The stock's valuation at 0.22 P/S offers potential if operational improvements materialize.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Flux Power designs and manufactures lithium-ion battery packs for industrial vehicles. Its sustainable energy solutions power material handling equipment like forklifts and airport ground support vehicles.
Read more on FLUX →Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →